期刊文献+

长春瑞滨联合吡柔比星治疗多发性骨髓瘤临床观察 被引量:1

Clinical observation on navelbine combined with pirarubicin in treatment of multiple myeloma by combined chemotherapy
下载PDF
导出
摘要 目的观察长春瑞滨治疗多发性骨髓瘤的临床疗效和毒副作用。方法治疗组在VAD方案中,用长春瑞滨(NVB)代替长春新碱(VCR)与吡喃阿霉素、地塞米松组成NTD方案治疗多发性骨髓瘤10例;对照组以长春地辛(VDS)代替长春新碱与吡喃阿霉素、地塞米松组成VTD方案治疗多发性骨髓瘤10例,比较两组的疗效和毒副作用。结果两组总有效率均为70.0%;VTD组周围神经毒性发生率为40.0%,NTD组为10.0%。结论NTD方案对多发性骨髓瘤有较好的治疗效果,周围神经毒性有明显降低的趋势。 Objective To investigate the clinical efficacy and toxicity of navelbine(NVB) in treatment of multiple myeloma. Methods Ten patients with multiple myeloma were treated by NTD regimen(NVB, pimrubicin, dexamethasone). In the control group, 10 patients were treated by VTD regimen(vindesine, pirambicin and dexamethasone) .Results The overall response rate of two group were all 70.0% .qhe rate of neurologic toxicity in VTD group and NTD group were 40.0% and 10.0% respeetively.Conclusion There was fairly efficacy of NTD regimen in patients with multiple myeloma. Compared with VTD regimen, the rote of neurologic toxicity tended to decrease in NTD regimen.
出处 《中国肿瘤临床与康复》 2005年第5期431-433,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 多发性骨髓瘤 化学疗法 长春瑞滨 吡柔比星 Multiple myeloma/chemothempy Navelbine Pirarubicin
  • 相关文献

参考文献7

  • 1Weber BL, Vogel C, Jones S, et al. Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer[J].J Clin Oncol,1995,13(11):2722-2730.
  • 2Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer:results of a European multi-center trial including 612 patients[J].J Clin Oncol,1994,12(2):360-367.
  • 3Conroy T, Etienne PL, Adenis A,et al. Phase Ⅱ trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group[J].J Clin Oncol,1996,14(1):164-170.
  • 4马明信,虞积仁.长春新碱,阿霉素和地塞米松治疗难治性多发性骨髓瘤[J].中华内科杂志,1989,28(5):267-269. 被引量:7
  • 5陈洁,董戴玉,杨镜明.长春瑞滨为主的联合方案治疗恶性淋巴瘤临床观察[J].肿瘤防治杂志,2003,10(2):201-202. 被引量:9
  • 6Devizzi L, Santoro A, Bonfante V, et al.Vinorelbine:an active drug for the management of patients with heavily pretreated Hodgkin's disease[J].Ann Oncol,1994,5(9):817-820.
  • 7Balzarotti M, Santoro A, Tondini C, et al. Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma[J].Ann Oncol,1996,7(9):970-972.

共引文献14

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部